| Schedule of Earnings Per Share |
Net
income per common and diluted share were calculated as follows for the three- and nine-month periods ended January 31, 2026 and 2025:
Schedule of Earnings Per Share
| | |
Three
Months
Ended
January 31, 2026 | | |
Three
Months
Ended
January 31, 2025 | | |
Nine
Months
Ended
January 31, 2026 | | |
Nine
Months
Ended
January 31, 2025 | |
| Net
income (loss) attributable to common stockholders – basic | |
$ | (1,812,844 | ) | |
$ | (3,006,537 | ) | |
$ | (7,584,385 | ) | |
$ | (7,754,208 | ) |
| Adjustments
to net income | |
| — | | |
| — | | |
| — | | |
| — | |
| Net
income (loss) attributable to common stockholders – diluted | |
$ | (1,812,844 | ) | |
$ | (3,006,537 | ) | |
$ | (7,584,385 | ) | |
$ | (7,754,208 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Weighted
average common shares outstanding - basic | |
| 5,612,356 | | |
| 1,915,367 | | |
| 4,432,039 | | |
| 1,119,479 | |
| Effect
of dilutive securities | |
| — | | |
| — | | |
| — | | |
| — | |
| Weighted
average common shares outstanding – diluted | |
| 5,612,356 | | |
| 1,915,367 | | |
| 4,432,039 | | |
| 1,119,479 | |
| | |
| | | |
| | | |
| | | |
| | |
| Earnings
(loss) per common share - basic | |
$ | (0.32 | ) | |
$ | (1.57 | ) | |
$ | (1.71 | ) | |
$ | (6.93 | ) |
| Earnings
(loss) per common share - diluted | |
$ | (0.32 | ) | |
$ | (1.57 | ) | |
$ | (1.71 | ) | |
$ | (6.93 | ) |
|